论文信息 - Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes. - 字舞流文

Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes.

K. Kabashima | Y. Tokura | Miwa Kobayashi

[1] Y. Tokura,et al. Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes. , 2005, Journal of dermatological science.

[2] Y. Tokura,et al. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. , 2004, Cellular immunology.

[3] T. Tezuka,et al. Epinastine Inhibits Eosinophil Chemotaxis and Adhesion Molecules in Atopic Dermatitis , 2003, Skin Pharmacology and Physiology.

[4] Y. Tokura,et al. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells. , 2003, Cellular immunology.

[5] K. Tasaka. Epinastine: An update of its pharmacology, metabolism, clinical efficacy and tolerability in the treatment of allergic diseases. , 2000, Drugs of today.

[6] M. Nitschke,et al. In vitro investigations with the histamine H1 receptor antagonist, epinastine (WAL 801 CL), on isolated human allergic effector cells , 2000, Inflammation Research.

[7] K. Asano,et al. Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro. , 2000, Mediators of inflammation.

[8] T. Kohyama,et al. A novel antiallergic drug epinastine inhibits IL-8 release from human eosinophils. , 1997, Biochemical and biophysical research communications.